Researchers predict age of T cells to improve cancer treatment

Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body’s own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin’s lymphoma, chronic lymphocytic leukemi…

MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia

HOUSTON – The interplay between a major tumor-suppressing gene, a truncated chromosome and two sets of microRNAs provides a molecular basis for explaining the less aggressive form of chronic lymphocytic leukemia, an international team of researchers…

Targeted agent shows promise for chronic lymphoid leukemia

COLUMBUS, Ohio — Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have identified an experimental agent that targets chronic lymphocytic l…

Get more stuff like this
in your inbox

From anti-aging to the search for alien life, we promise to never bore.